HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arglabin: From isolation to antitumor evaluation.

Abstract
Arglabin belongs to guaianolide class of sesquiterpene lactones, isolated from Artemisia species. The molecule bears a 5,7,5-tricyclic ring system having five contiguous stereo centers in which the two five membered rings are trans-annulated. Arglabin shows promising antitumor activity against different tumor cell lines. The antitumor activity of arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30% of all human tumors. It actually inhibits the incorporation of farnesyl pyrophosphate into human H-ras proteins by the enzyme farnesyl transferase (FTase). The present review is an attempt to summarize the chemistry and biology of this molecule since its isolation in 1982. It embodies the isolation, structure elucidation, stereo chemical description, structural classification, chemical synthesis, structural modifications and antitumor evaluation reported till date.
AuthorsShabir H Lone, Khursheed A Bhat, Mohd A Khuroo
JournalChemico-biological interactions (Chem Biol Interact) Vol. 240 Pg. 180-98 (Oct 05 2015) ISSN: 1872-7786 [Electronic] Ireland
PMID26327249 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Sesquiterpenes
  • Sesquiterpenes, Guaiane
  • arglabin
Topics
  • Antineoplastic Agents (pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Humans
  • Molecular Structure
  • Proto-Oncogene Mas
  • Sesquiterpenes (chemistry, isolation & purification, pharmacology)
  • Sesquiterpenes, Guaiane

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: